New Delhi, May 5 -- Wockhardt, the pharmaceutical and biotechnology major, saw its shares surge sharply in Monday's intraday session, December 1, rising 12.55% to reach a 9-month high of Rs.1,604 apiece as investors cheered the company's turnaround performance in the quarter ended March.

The company on Monday reported a net profit of Rs.164 crore in Q4FY26 as against a net loss of Rs.45 crore in the year-ago quarter, led by strong growth in revenue, which jumped to Rs.965 crore. The higher revenue was supported by a strong revival in its biotech and emerging markets businesses.

Revenue from the India-branded business rose to Rs.112 crore from Rs.95 crore, while revenue from the emerging markets segment stood at Rs.320 crore in Q4FY26, r...